Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Amino Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1260364C reveals a novel enzymatic hydrolysis using bulky esters for high-purity beta-amino acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced Ir-catalyzed asymmetric hydrogenation for beta-amino acid esters. Delivers 99% ee and 95% yield. Reliable pharmaceutical intermediates supplier for scalable production.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN104974001A details a novel cinchona alkaloid-catalyzed route for high-purity beta-branched alpha-amino esters, offering significant supply chain and cost advantages.
Novel visible-light method for beta-aminocarbonyls using oxalyl oxime esters. High yield, mild conditions. Cost-effective pharma intermediate manufacturing solution.
Patent CN106831474B reveals a one-step rhodium-catalyzed synthesis for anticancer intermediates, offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Novel catalytic method using p-nitrobenzoic acid offers cost-effective synthesis of beta-amino esters with high regioselectivity for reliable API manufacturing.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.